A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

Clinical trial NCT03571568 · RECRUITING

Trial details

NCT number: NCT03571568
Sponsor: BioInvent International AB
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Indolent B-Cell Non-Hodgkin Lymphoma

Start date: 2018-05-16
Primary completion: 2026-09-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.